Carl Russo, a director and 10% owner of Calix, Inc. (NYSE:CALX), filed a Form 4 on November 9, 2026, disclosing the sale of 75,000 shares of common stock on November 6, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • First sale tranche: 71,958 shares disposed of at a weighted average price of $31.0346, with individual transaction prices ranging from $30.73 to $31.72.
  • Second sale tranche: 3,042 shares disposed of at a weighted average price of $31.8778, with individual transaction prices ranging from $31.755 to $31.92.
  • 10b5-1 plan: According to the filing, the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on April 23, 2026.
  • Indirect ownership after sales: Following the transactions, Russo beneficially owns 1,494,188 shares indirectly through The Crescentico Trust, of which he is trustee.
  • Direct ownership: The filing also reports 3,958,037 shares held directly by Russo.
  • Additional indirect holding: 13,782 shares are held indirectly through Equanimous Investments, where Russo and Tim Pasquinelli are managing members with shared voting and investment power.

Details of Carl Russo's November 6 Calix Share Sales

According to the Form 4 filed with the SEC on November 9, 2026, Carl Russo, identified as both a director and 10% owner of Calix, Inc. (NYSE:CALX), sold a combined 75,000 shares of Calix common stock on November 6, 2026. The sales were executed in two separate tranches, both coded as disposals ("S") under the indirect ownership of The Crescentico Trust, with Russo named as trustee.

The first tranche covered 71,958 shares at a weighted average sale price of $31.0346. The filing notes these shares were sold in multiple transactions at prices ranging from $30.73 to $31.72, inclusive. The second tranche consisted of 3,042 shares at a weighted average sale price of $31.8778, with individual prices ranging from $31.755 to $31.92. The filing states that full information on the number of shares sold at each price is available upon request.

The filing discloses that all sales were made pursuant to a Rule 10b5-1 trading plan adopted on April 23, 2026. Separately, the filing identifies 13,782 shares held indirectly through Equanimous Investments, where Russo and Tim Pasquinelli serve as managing members. The filing states each individual "disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein." The Form 4 was signed by Tom Gemetti as attorney-in-fact for Carl Russo.

What Was Disclosed

Carl Russo disclosed the sale of 75,000 shares of Calix common stock on November 6, 2026, through The Crescentico Trust under a pre-established Rule 10b5-1 plan, with post-transaction beneficial ownership across direct and indirect holdings also reported.